MOV'D + Fitbit Monitoring for Sedentary Lifestyle

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help people who sit too much at work become more active. Participants will either track their activity with a Fitbit or join a group that uses a Fitbit and receives support through social media for short exercise breaks. The researchers aim to determine if these methods, including the MOV'D (Move Often eVery Day) program, can increase active hours and reduce sitting time. This trial suits individuals with a smartphone, who work a desk job most of the time, and can safely exercise. As an unphased trial, it offers a unique opportunity to explore new ways to improve health and activity levels.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the MOV'D intervention is safe?

Research has shown that using a Fitbit to track physical activity, as in the MOV'D program, is generally safe. The MOV'D program includes short exercise breaks and social media support to encourage less sitting and more movement. Participants in similar programs have reported positive experiences without major safety issues. Although specific safety data for MOV'D is not available, fitness trackers and short exercise routines are usually well-tolerated.12345

Why are researchers excited about this trial?

Researchers are excited about the MOV'D protocol for tackling sedentary lifestyles because it combines technology and social support in a unique way. Unlike traditional approaches that might rely solely on self-monitoring or professional intervention, MOV'D pairs participants with a Fitbit for activity tracking and integrates a peer coaching system via a private Twitter group. This combination encourages consistent engagement and motivation through social interaction and shared goals, which could lead to more sustainable behavior changes compared to existing methods.

What evidence suggests that the MOV'D intervention and Fitbit self-monitoring could be effective for reducing sedentary lifestyle?

Research shows that taking short breaks to move around can boost activity levels without affecting work. Studies have found that just 2 minutes of moving large muscles can help reduce the negative effects of prolonged sitting. Walking, in particular, effectively improves health in those who sit a lot. In this trial, participants in the MOV'D plus Fitbit Self-Monitoring arm will use social media to share short exercise videos and tips, encouraging healthy breaks at work. Early results suggest that this approach can lead to positive changes in activity levels. Meanwhile, participants in the Fitbit-Only Self-Monitoring arm will track their physical activity using a Fitbit.16789

Who Is on the Research Team?

MA

Marily A. Oppezzo, PhD MS, RDN, DipACLM

Principal Investigator

Stanford University

Are You a Good Fit for This Trial?

This trial is for full-time employees who spend over half their work time sitting, can safely exercise (as determined by the PAR-Q), read English, and have a smartphone with internet. It's not suitable for those who don't meet these criteria.

Inclusion Criteria

English literacy
Safe to exercise, assessed by the Physical Activity Readiness Questionnaire (PAR-Q)
Have smartphone with internet capabilities
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to either the MOV'D intervention or a Fitbit-only control for one month

4 weeks
Remote participation

Follow-up

Participants are monitored for changes in MVPA minutes and active workday hours

4 weeks
Remote monitoring

What Are the Treatments Tested in This Trial?

Interventions

  • Fitbit Self-Monitoring
  • MOV'D (Move Often eVery Day)
Trial Overview The MOV'D program aims to reduce long sitting periods at work using 'exercise snacks'—short bursts of activity—and behavior change techniques shared via social media support groups. Participants will also self-monitor with Fitbit devices.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: MOV'D plus Fitbit Self-MonitoringExperimental Treatment2 Interventions
Group II: Fitbit-Only Self-MonitoringActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Published Research Related to This Trial

Cancer survivors using wearable activity trackers, like Fitbits, have shown an increase in physical activity, which is important for reducing negative effects from cancer treatments and improving overall health outcomes.
The review identified 13 relevant studies, including 8 randomized controlled trials, indicating a need for further research to better understand how these devices can effectively promote physical activity and weight management in cancer survivors.
Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies.Coughlin, SS., Caplan, LS., Stone, R.[2020]
A systematic review of 14 studies found a weak-to-moderate positive association between physical activity measured by wearable activity monitors (WAMs) and performance status (PS) in cancer patients, indicating that more activity may correlate with better performance.
Conversely, there was a weak-to-moderate negative association between sedentary behavior (SB) metrics from WAMs and PS, suggesting that less sedentary time could be linked to improved performance, but WAM data should not replace physician assessments.
The association between wearable activity monitor metrics and performance status in oncology: a systematic review.Kos, M., Pijnappel, EN., Buffart, LM., et al.[2022]

Citations

Protocol for a Randomized Controlled Pilot Trial - PMCSpecifically in worksite interventions, breaks involving movement were shown to successfully increase overall levels of physical activity, maintain productivity ...
A Work-Based, Fully Remote, and Peer-Supported ...The negative effects of prolonged sitting can be ameliorated with as little as 2 minutes of large muscle movement. Further, cardiovascular ...
MOV'D + Fitbit Monitoring for Sedentary LifestyleThis trial tests the MOV'D program, which sends short exercise videos and tips via social media to help people take breaks from sitting at work.
Movement Behavior and Health Outcomes among ...Walking was identified as the most effective method to improve MSD and cardiometabolic outcomes among sedentary workers [46,47,48] since walking changes the ...
Protocol for the Move Often eVery Day (MOV'D) PilotBACKGROUND Prolonged sitting and lack of moderate to vigorous physical activity represent two independent risk factors for myriad poor health outcomes.
Peer Motivation Coaches, Social Media-based Support ...The MOV'D intervention is a remotely-delivered, peer-supported intervention that delivers exercise snack (2-5 minutes of moderate to vigorous activity) and ...
Poor Sleep, Sedentary Behavior, and Secondary ...Move Often eVery Day (MOV'D): An occupationally-tailored, remotely-delivered, socially-supported short exercise break intervention to decrease sedentary ...
Findings From a Pilot StudyThis qualitative study employed semi-structured interviews with 20 office workers who completed a pilot exercise snack intervention called Move Often eVeryDay ...
The physiological benefits of sitting less and moving moreA sedentary lifestyle has been linked to negative health effects, particularly cardiovascular and metabolic health, and may increase mortality risk to a similar ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security